BillionToOne, Inc. (BLLN)
$93.07-5.12%Close
SELLCRISIS · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4.3B
- Beta
- 0.34
- P/E (TTM)
- 144.82
- Short % float
- 51.61%
- Days to cover
- 3.9
- SI change
- +7.3%
- 1W
- -14.66%
- 1M
- -5.77%
- vs SPY 1W
- -15.08%
- vs SPY 1M
- -7.83%
Industry peers
FMP comparable companies · ranked by market cap
- NTRABUYNatera, Inc.$57.4BBULLQ 30$400.65-0.73%
- GHSELLGuardant Health, Inc.$22.9BCRISISQ 23$170.69-2.79%
- GRALBUYGRAIL Inc.$5.9BRECOVERYQ 67$137.28-2.28%
- VCYTBUYVeracyte, Inc.$3.6BBEARQ 14$44.65-2.68%
- WGSSELLGeneDx Holdings Corp.$2.1BCRISISQ -4$71.52-5.21%
- FLGTBUYFulgent Genetics, Inc.$584MRECOVERYQ 13$20.58-1.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on BLLN?
- LOPJLB’s latest quantitative signal on BillionToOne, Inc. (BLLN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BLLN in?
- BillionToOne, Inc. (BLLN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does BillionToOne, Inc. (BLLN) do?
- BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product por…